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Glucose hypometabolism and gray matter atrophy are well known consequences
of Alzheimer’s disease (AD). Studies using these measures have shown that the
earliest clinical stages, in which memory impairment is a relatively isolated feature,
are associated with degeneration in an apparently remote group of areas—mesial
temporal lobe (MTL), diencephalic structures such as anterior thalamus and mammillary
bodies, and posterior cingulate. These sites are thought to be strongly anatomically
inter-connected via a limbic-diencephalic network. Diffusion tensor imaging or DTI—an
imaging technique capable of probing white matter tissue microstructure—has recently
confirmed degeneration of the white matter connections of the limbic-diencephalic
network in AD by way of an unbiased analysis strategy known as tract-based spatial
statistics (TBSS). The present review contextualizes the relevance of these findings, in
which the fornix is likely to play a fundamental role in linking MTL and diencephalon.
An interesting by-product of this work has been in showing that alterations in diffusion
behavior are complex in AD—while early studies tended to focus on fractional anisotropy,
recent work has highlighted that this measure is not the most sensitive to early changes.
Finally, this review will discuss in detail several technical aspects of DTI both in terms of
image acquisition and TBSS analysis as both of these factors have important implications
to ensure reliable observations are made that inform understanding of neurodegenerative
diseases.
Keywords: neurodegenerative diseases, Alzheimer’s disease neurobiology, axonal loss, circuit of Papez, long
association tracts, splenium, DTI criteria, Alzheimer’s disease biomarkers
INTRODUCTION
Alzheimer’s disease (AD) is characterized, histopathologically,
by amyloid deposition and neurofibrillary tangles (composed
of hyperphosphorylated tau); these features occur in somewhat
topographically distinct distributions in the brain. The ultimate
outcome of AD is neuronal loss though exactly how histopatho-
logical features interact with each other and how they relate,
in turn, to neuronal degeneration remains rather unclear. It
seems reasonable to assume, nonetheless, that neuronal—and
synaptic—loss is critical to the development of cognitive impair-
ment. To date, therapeutic attempts to slow the course of AD have
targeted the histopathology. A possible alternative, or even com-
plimentary approach, might be to understand what makes some
neuronal populations in the central nervous system more vulner-
able to degeneration than others with a view to finding ways to
make neurons less vulnerable to pathological insult—regardless
of what that pathological insult might be. Such an approach
requires a precise understanding of the spread of neurodegener-
ation and this can only be achieved by studies in humans rather
than disease models.
Historically, in vivo work to understand the landscape of neu-
rodegeneration in AD has focused on atrophy detection using
T1-weighted magnetic resonance imaging (MRI) and metabolic
studies using (18F)-2-fluoro-deoxy-D-glucose positron emission
tomography (FDG-PET)—the latter being primarily a marker
for synaptic loss. Both of these modalities typically focus on
changes in gray matter (GM) and have tended to show what,
at first glance, appear to be different profiles of degeneration
(Ishii et al., 2005). Structural MRI has been good at highlight-
ing mesial temporal lobe (MTL) atrophy (Du et al., 2001; Jack
et al., 2002, 2004), while FDG-PET has typically highlighted
early changes in posterior association cortex (Minoshima et al.,
1995) with the posterior cingulate region in particular appear-
ing as the first hypometabolic region in very early symptomatic
AD (Minoshima et al., 1997; Nestor et al., 2003a). This appar-
ent discrepancy between structural MRI and FDG-PET may well,
however, be technical. For instance, much of the work on MTL
atrophy derives from region-of-interest (ROI) studies that did
not examine for atrophy elsewhere. Where whole brain analy-
ses were conducted, most used the voxel-based morphometry
(VBM) technique (Ashburner and Friston, 2000) though recent
evidence highlights that although this method is good at iden-
tifying MTL atrophy, it is relatively insensitive to atrophy in
the isocortical ribbon (Diaz-De-Grenu et al., 2014); in contrast,
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using the Freesurfer’s cortical thickness method (Dale et al., 1999;
Fischl et al., 1999), atrophy of the cortical ribbon in posterior
association cortex emerges in a pattern highly reminiscent of
that seen with FDG-PET (Diaz-De-Grenu et al., 2014). Similarly,
although ROI studies in the cortical ribbon are rare, manual vol-
umetry of the posterior cingulate region in MCI-stage AD has
confirmed comparable degrees of atrophy to that seen in the
hippocampus (Choo et al., 2010; Pengas et al., 2010). Looking
at the apparent discrepancy in these imaging modalities from
the FDG-PET side, voxel-based analysis (VBA) appears relatively
insensitive to MTL changes in early AD; however, using MRI-
derived ROIs to calculate cerebral metabolic rates (i.e., quantified
imaging), FDG-PET identified significant hypometabolism not
only in the posterior cingulate but also the MTL, as well as ante-
rior thalamus and mammillary bodies (Nestor et al., 2003b). This
“limbic-diencephalic” network, therefore, appears to be the cor-
relate of very early symptomatic AD when memory impairment
is a relatively isolated feature. It is interesting, therefore, that these
network structures—MTL, posterior cingulate, anterior thalamus
and mammillary bodies—which are connected through the cir-
cuit of Papez (Papez, 1937), have all been individually implicated
from focal lesions in human amnesia.
The hypothesis that these structures are degenerating in con-
cert predicts that white matter (WM) projections between these
areas—such as, for instance the fornix, which links the MTL with
the diencephalon—should also show signs of degeneration. To
test such hypotheses as well as to understand how degeneration
in AD may impact on areas remote from GM degeneration more
generally, the relatively more recent technique of diffusion tensor
MRI offers considerable promise. Diffusion MRI enables map-
ping of WM microstructure alterations in development, aging
and neurological disorders, and has therefore become an impor-
tant tool in the study neurodegeneration. Parenchymal WM is
composed of bundles of axons (or fiber tracts) that intercon-
nect GM areas. The diameter of neuronal fibers is well below
MRI resolution but the technique can be sensitized to measure
the displacement of water molecules as a surrogate marker of
tract integrity. Axonal membranes, myelin sheaths and cytoskele-
tal constituents such as microtubules and neurofilaments are long
structures that may hinder water diffusion preferentially per-
pendicular to their length; this phenomenon enables MRI to
detect abnormalities caused by neurodegenerative diseases such
as loss of fibers, demyelination, damage within fibers or to sup-
port tissue around them (Beaulieu, 2002). The technique remains
fairly new and there has been a relatively steep learning curve in
terms of understanding and interpreting diffusion tensor imag-
ing (DTI) (Alger, 2012; Winston, 2012); this learning process
is far from over. What is clear at this time is that technical
factors—both in terms of acquisition parameters and analysis
methods—play a more important role in terms of generating
spurious findings compared to older modalities such as struc-
tural T1-weighted imaging and FDG-PET. The outcome being
that the DTI literature in AD can come across as a confusing jum-
ble of inconsistent abnormalities—an unsurprising observation
considering DTI’s vulnerability to spurious results when subopti-
mal experimental designs are employed. The prescription of DTI
acquisitions with fewer-than-recommended diffusion-encoding
directions, low b-values or thick slices; the study of mild cog-
nitive impairment (MCI) cohorts without clinical outcome and
the detrimental effect of Gaussian smoothing in post-processing
pipelines are the most likely contributors to such inconsistencies.
It is crucial therefore that clinicians and researchers have
some understanding of the pitfalls that can arise from inadequate
methods in order to interpret what have often been rather con-
tradictory results in DTI studies. This review will focus on what
we have learned from DTI in AD to date, but also will go into
some detail in explaining themethodological issues that can cause
problems for DTI studies.
THE PHYSICAL BASIS OF DTI
The present section is not intended as a comprehensive descrip-
tion of DTI theory—for that, extensive reviews can be found
elsewhere (Kingsley, 2006a,b,c). It aims, however, to provide an
intuitive understanding of the method and an appreciation of
the possible tensor dynamics that can arise with neurodegen-
eration; these are important theoretical considerations because
diffusion, as measured with the “single tensor” model (Basser
et al., 1994b), is based on a number of assumptions that lead
to certain limitations; limitations that have been extensively dis-
cussed in the diffusion MRI literature (Jones and Cercignani,
2010; Jones et al., 2013b), but that are often overlooked in clin-
ical studies. Nevertheless, DTI is a powerful technique to study
neurodegenerative diseases; thus, an overview of its theoretical
foundations will also enable a more clear understanding of the
discoveries that have been made to date in AD. The theoretical
underpinning of DTI can, however, seem impenetrable for non-
specialists even when most of the background mathematics is
omitted, as is the case in this section. For readers, therefore, who
might find the physics described in this section too daunting, we
suggest simply focusing on the Figures and their captions; and
with a brief understanding of what a diffusion tensor means, one
can then skip on to the following section “Technical considera-
tions for clinical DTI studies” for a discussion of the factors that
influence the suitability of DTI scans for clinical studies.
Brownian motion, also known as “self-diffusion,” is a physi-
cal phenomenon arising from matter’s intrinsic thermal energy
that leads to pseudo-random kinetic fluctuations. Such molec-
ular thermal motion is named after Robert Brown—a Scottish
botanist—who first observed such behavior in grains of pollen
suspended in water (Brown, 1828). A full mathematical descrip-
tion emerged a few decades later when Adolf Fick—a physiolo-
gist studying mass transport in saline solutions—proposed that
microscopic motion could be seen as a probability density func-
tion (pdf ) of a particle’s location in space and time, i.e., as the
likelihood of finding a particle in a certain place at a certain time,
and then went on to predict that self-diffusion must be governed
by such time-dependent probabilistic behavior (Fick, 1855). Soon
after the turn of the 20th century, Albert Einstein solved the gen-
eral case of Fickian diffusion to provide an analytical answer to
the practical question: how far do “free particles” travel “in aver-
age” during a time interval? Einstein proposed a simple “random
walk” model comprising a series of discrete, unrestricted, inde-
pendent and uncorrelated steps, which led him to discover that for
such boundary conditions, Fick’s pdf is a Gaussian distribution
Frontiers in Aging Neuroscience www.frontiersin.org October 2014 | Volume 6 | Article 266 | 2
Acosta-Cabronero and Nestor DTI Review in AD
whose width—a measure of average molecular displacement—is
modulated by two factors: time and a parameter dependent on
fluid viscosity and temperature; he figured the latter must be a
self-diffusion coefficient, D (Einstein, 1905) (see Figure 1A).
Since the inception of “spin echoes” in 1950, the MR signal has
been known to be sensitive to molecular thermal motion (Hahn,
1950; Carr and Purcell, 1954; Torrey, 1956), which hereafter will
be assumed to be that of hydrogen protons in water molecules
within human brain tissue. Applying Einstein’s relationship, it
was determined that “free diffusion” under the effect of a steady
magnetic field “gradient” attenuates the MR signal. This was
first observed because field gradients (i.e., gradual increments or
decrements in magnetic field strength) occur naturally when an
experimental sample is introduced into the uniform magnetic
field of a magnet and disturbs it. Magnetic field gradients, how-
ever, can be applied artificially to vary the main field gradually
along one direction; such gradual field change, in essence, labels
protons according to their spatial position. Stronger gradients,
therefore, have the capability of giving a wider range of spatial
signatures that result in higher image resolutions (if we refer to
imaging gradients) or finer sensitivity to motion (if we refer to
diffusion MRI). It was soon realized, however, that measuring
self-diffusion through the application of sustained gradients was
inconvenient and largely ineffective. Then in 1965, Stejskal and
Tanner proposed that the amount of diffusion weighting in the
MR signal could be finely controlled with a pair of identical,
short-lived, magnetic field gradients (Stejskal and Tanner, 1965)
(see Figure 1B). Pulsed gradients sequentially label, and then
unlabel, protons according to their position; with the result that if
a proton moves to a different location after a “diffusion time”—
i.e., when the second gradient is applied—, the proton gets
assigned a wrong label and returns less signal according to how far
it has moved. This principle—the basis for most diffusion MRI
acquisitions today—results in an overall signal intensity atten-
uation due to free diffusion that depends on the self-diffusion
coefficient,D, and the gradient characteristics. For simplicity, and
FIGURE 1 | Measurement of the “self-diffusion” coefficient with
magnetic resonance. (A) Self-diffusion is a special case of diffusion that
describes the relentless motion of microscopic particles in a substance. Such
motion is random—it can be described by a “Gaussian” distribution whose
width determines how far particles travel on average after some time; the
important thing to remember is that only time, the “diffusion time,” and the
“self-diffusion coefficient,” D, modulate this width. (B) Illustration of a
magnetic resonance pulse sequence that is sensitive to self-diffusion: (i) an
“excitation pulse” gives some energy to water protons; (ii) then the first
“gradient” encodes where they are; (iii) and some (diffusion) time later, a
second gradient decodes their position by giving them a “signal penalty”
according to how far they have moved away from their original position; (iv)
as a result of this penalty, protons that have moved furthest, return the least
signal. The overall signal attenuation is a function of D and the gradient
characteristics—i.e., intensity (G), duration (tG ) and diffusion time
(tD )—usually conglomerated into a single term known as the “b-value.” (C)
Visual representation of the linear fit required to quantify D using two signals:
a diffusion weighted measurement (i.e., with a non-zero b-value), S, that
must be normalized by a measurement without diffusion weighting, S0 (also
often called b0); D can be inferred as the “negative” of the slope.
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because in MRI there is a complex interaction between diffusion
and imaging gradients, the overall effect of motion-sensitizing
gradients is often synthesized into a so-called “b-value.” This is
convenient because the signal attenuation due to diffusion can
be expressed simply by an exponential function of D and b, i.e.,
S ∝ exp (−bD). As in any spin echo experiment, however, the
signal also decays due to transverse relaxation (T2) effects; thus,
for the signal to depend only on the effects of water mobility, it
must be normalized by a reference measurement without diffu-
sion weighting, S0, also known in DTI jargon as a “b0 scan.” Two
measurements, therefore, are sufficient to infer a diffusion coef-
ficient as: D = −ln (S/S0) /b; or in visual representation terms,
that D is the negative of the slope connecting the two data points
in Figure 1C.
The information that a Stejskal-Tanner experiment provides,
however, is limited because the positions of resonant protons can
only be encoded along the direction of the applied field gradient;
thus, D only reflects the effect of self-diffusion along that specific
spatial dimension. This is enough to characterize an isotropic
medium, e.g., if measuring water’s self-diffusion in a bucket,
because diffusion measured in a given dimension will be same as
that of every other dimension, but to probe a complex systemwith
multiple, rotationally variant diffusion behaviors such as biologi-
cal tissue one needs, in theory, an infinite number of observations
with sensitizing gradients along an infinite number of diffusion
orientations.
In an attempt to capture such directional dependency
while keeping experimental requirements feasible, Basser et al.
proposed the generalization of Einstein’s equation by extending
the Gaussian pdf idea to a second order, symmetric, definite-
positive covariance matrix, D, and this is the diffusion tensor
(Basser et al., 1994a):
D =
⎛
⎝
Dxx Dxy Dxz
Dyx Dyy Dyz
Dzx Dzy Dzz
⎞
⎠ (1)
D is a reciprocal matrix with Dxy = Dyx, etc—i.e., it only has
six “independent” scalar elements: Dxx, Dxy, Dxz , Dyy, Dyz, and
Dzz ; thus, in order to reconstruct a diffusion tensor, the mini-
mum requirements are one S0 (b = 0 s/mm2 or b0) measurement
and six diffusionmeasurements applying gradients along six non-
collinear orientations (see Figure 2A)—i.e., Nd, the number of
diffusion gradient directions, must be at least 6, though Nd can
be larger with obvious benefits (see Figure 2B). The single tensor
model proposed by Basser et al. requires that all diffusion direc-
tions (b-vectors), b-values and b0 information (which can also
be provided through multiple scans to improve stability) must
be stored as a B-matrix, leading to a linear system of equations
that can be solved for the six independent terms of D and for S0
efficiently across an entire imaging volume.
Another convenient feature of the diffusion tensor is that it
can be expressed in its quadratic form as an ellipsoidal surface
that characterizes the water displacement probability at a given
diffusion time, i.e., an ellipsoid that visualizes the 3D charac-
ter of water mobility; though in the present form, i.e., that in
FIGURE 2 | The “diffusion tensor.” (A) Six combinations of gradients
applied with different intensities along three orthogonal orientations (x, y,
and z), and a measurement without diffusion weighting, are the minimum
requirements to probe diffusion in a 3D space; each non-collinear
combination is called a “diffusion direction.” (B) A larger number of
diffusion directions, Nd, can estimate the directional dependence of
microstructural restrictions to water diffusion with greater precision. (C)
Basser et al. (1994b) proposed the formulation of a diffusion tensor
(represented by an ellipsoid) to capture diffusion behaviors in 3D with a
finite Nd. (D) The tensor can be rotated to match the principal direction of
diffusion, i.e., in white matter, the first eigenvector (ε1) matches the
predominant fiber tract orientation; thus, the largest eigenvalue (λ1,
known as “axial diffusivity”) quantifies water mobility along this
orientation. Analogously, ε2 and ε3 define the plane perpendicular to the
axonal arrangement so that λ2 and λ3 can be averaged as a “radial
diffusivity” (RD). In addition, all three eigenvalues can be averaged to
estimate the “mean square displacement” of water molecules—that is,
the “mean diffusivity” (MD).
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Equation (1), D is still rotationally variant because it depends on
the principal diffusion orientation relative to the x, y, and z axes
of the scanner or to whatever coordinate system the b-vectors
were in (see Figure 2C). D, however, is positive and symmetric
regardless of such orientation; thus, using linear algebra, it can
be easily made diagonal for a specific orientation—i.e., it can be
decomposed into a set of orthonormal eigenvectors and related
eigenvalues (see Figure 2D):
D =
⎛
⎝
ε1
ε2
ε3
⎞
⎠
⎛
⎝
λ1 0 0
0 λ2 0
0 0 λ3
⎞
⎠( ε1 ε2 ε3
)
. (2)
In essence, the diagonalization step in Equation (2) rotates the
principal axes of D to match the principal directions of diffusiv-
ity, leading, as a result, to a diffusion tensor that is rotationally
invariant for each imaging “voxel.”
A number of metrics can be derived from the diffusion
tensor; for example, the 3D “mean square displacement” of water
molecules during a diffusion time can be derived by averaging the
three tensor eigenvalues to form a DTI metric known as “mean
diffusivity”: MD = (λ1 + λ2 + λ3)/3. In addition, the rotational
invariance of the diffusion tensor has clear advantages because
water molecules can be generally assumed to “diffuse” due to
their thermal energy more readily along the length of a uniaxial
environment than perpendicular to it. It is, thus, commonly
assumed when referring to, e.g., parenchymal WM, that the
eigenvector, ε1, associated with the largest eigenvalue, λ1—
known as “axial diffusivity”—maps the principal orientation of a
fiber tract. Similarly, diffusivities along ε2 and ε3—typically aver-
aged to form “radial diffusivity,” i.e., RD = (λ2 + λ3)/2—reflects
the diffusion behavior transverse to an axonal path. Therefore,
the inter-relationship between eigenvalues—i.e., between axial
and radial diffusivities—contains relevant information about
the geometry of the restricting microstructure. For example,
in a scenario where axons are tightly packed together such as,
e.g., the mid-sagittal corpus callosum, water molecules are more
restricted perpendicular to the axons, hence λ1 >> λ2 ≥ λ3, or
λ1 >> RD—i.e., it can be represented as a cigar-shaped diffusion
ellipsoid with the long axis parallel to the axons (see Figure 3). In
other regions, however, where, e.g., two tightly packed WM bun-
dles cross, water molecules in the extra-cellular space might travel
more freely across a plane, λ1 ≥ λ2 >> λ3, hence λ1 > RD—
i.e., the ellipsoid adopts a planar geometry; whereas in WM areas
where multiple fiber bundles cross, or in GM or cerebrospinal
fluid (CSF), where water diffusion does not exhibit a preferential
orientation because obstacles are randomly distributed in space
or because there are no restrictions at all, the ellipsoid is largely
“isotropic,” i.e., λ1 ≈ λ2 ≈ λ3, thus λ1 ≈ RD. The eccentricity
of the diffusion ellipsoid, therefore, is an important property that
can provide useful information about the biological tissue under
investigation. This property is typically measured using the “sec-
ond moment” of the diffusion tensor, because of its robust noise
properties, by a metric known as fractional anisotropy (FA): FA =√
3/2
√[
(λ1 − MD)2 + (λ2 − MD)2 + (λ3 − MD)2
]
/
(
λ1
2 + λ22 + λ32
)
(Basser and Pierpaoli, 1996). FA can be seen as the relative ratio
FIGURE 3 | Differential tensor behaviors in white matter. Cell
membranes are thought to be the main restricting boundary to water
mobility in white matter. As such, the ratio of axial to radial diffusivities,
commonly described by a metric known as “fractional anisotropy” (FA), can
reflect the coherence (sometimes thus the integrity) of packed axons in
white matter. FA approaches one in well-organized tracts, where the
diffusion ellipsoid is elongated along the principal tract orientation; and
tends to zero, in less coherent environments—i.e., in heterogeneous areas
of many crossing fibers, and in gray matter or cerebrospinal fluid—, where
the ellipsoid resembles a sphere. In the full complexity of white matter
microstructure, however, the ellipsoid can take a wider range of geometries
from that of a rugby ball to that of surfboard or a dish—with the degree of
sphericity and planarity dictated primarily—but not only—by axon packing
density, degree of myelination and/or the geometrical arrangement of
crossing, kissing and/or splaying fiber populations.
between axial and radial diffusivities, where its boundary sit-
uations are: (i) FA = 0 for a perfectly “ergodic” or “isotropic”
behavior, i.e., when λ1 = RD, and (ii) FA = 1 for 1D molecular
displacements in a 3D space, i.e., when RD is infinitesimally
small relative to λ1. The latter behavior is the extreme case for
“anisotropic” diffusion. In graphical terms (Figure 3), isotropic
diffusion (FA = 0) is a perfect sphere because it means water
can travel equally in all directions, whereas if water mobility
is restricted disproportionally along one or two dimensions in
space, FA moves away from zero.
The pseudo-random (Gaussian) nature of unrestricted diffu-
sional motion is, in turn, the theoretical basis supporting the
single tensor model in DTI (Basser et al., 1994b); this highlights,
however, one of DTI’s major limitations—it is based on an ideal-
ization. As already discussed, in WM, cytoarchitectural barriers
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hinder and physically restrict water mobility (see Figure 4A);
such nuisances to self-diffusion, therefore, impose a different set
of boundary conditions to Fick’s equation, making “walks” no
longer random. Instead, they become correlated and dependent
on the geometry of the restricting boundaries; thus leading to
pdf departures (narrowing) from the ideal Gaussian behavior
(see Figure 4A). In such scenarios, the diffusion tensor proposed
by Basser et al. does not contain enough terms to account for
the higher order effects in non-Gaussian molecular displace-
ment distributions; thus, they lead to the violation of DTI’s basic
assumption that the signal decay due to diffusion follows a sin-
gle exponential behavior. Consequently, the single tensor model
must be regarded as an approximation (Figure 4B); and the three
tensor-eigenvalues—if they describe restricted water motion—
are not true self-diffusion coefficients, but “apparent” measures
of diffusion or “diffusivities.”
A further caveat is that most DTI experimental designs assume
that tensor behaviors are independent of diffusion time—i.e., that
the brain parenchyma is a restricted environment in a “pseudo-
Gaussian” state, where diffusion time is long relative to the time
needed for water molecules to be hindered/restricted by cellu-
lar membranes or other microstructural components. Note that
the former are thought to be the primary microstructural restric-
tions to water diffusion in white matter (Beaulieu and Allen,
1994). This can be generally assumed to be valid because in
typical clinical situations, diffusion times range between 30 and
50ms, which translate to in vivo 1D molecular displacements
of 13–17μm. Such displacements are an order of magnitude
greater than, for example, the typical axon diameter in the cor-
pus callosum of young individuals, which is approximately 1μm
(Aboitiz et al., 1992)—though axons can also be much larger. In
lay terms, the reason this is important is that in order to know
that restrictions of water diffusion due to barriers in neural tissue
are present, one must measure long enough “diffusion paths” to
ensure water molecules have had a chance to “bounce off” some
barriers. Figure 5A illustrates this scenario, where such paths are
long relative to the distance between physical obstacles, enabling
DTI to sense differential bulk behaviors parallel and perpendic-
ular to white matter tracts. In patients with neurodegenerative
diseases, however, cellular membranes may become more perme-
able; or the extra-cellular space might be greater due to axonal
loss, demyelination, and/or glial pathology. Such effects—alone
or in combination—may result in local environments where, dur-
ing a given diffusion time, water molecules interact only partially
with microstructural boundaries. Figure 5C illustrates such a sce-
nario where some paths (e.g., the blue path) do not encounter
any obstacle during a given diffusion time, i.e., they behave as
if they were in an unrestricted medium. In theory, during dis-
ease progression the loss of large myelinated axons, or clumps of
adjacent tracts, may result in diffusion paths that cannot capture
the full extent of such “voidage.” This is the so-called “quasi-
restricted” regime, in which measurements depend on diffusion
time—i.e., if water molecules were allowed to diffuse twice as
far by doubling the diffusion time, microstructural boundaries
would be sensed again, resulting in smaller radial diffusivity rel-
ative to axial diffusivity, hence leading to a more anisotropic
tensor. Such behavior may inadvertently compromise whole brain
FIGURE 4 | The approximate nature of the “single tensor” model. (A)
“Restricted” diffusion processes such as those in white matter result in
displacement probabilities that are no longer accurately described by a
Gaussian “bell.” (B) Therefore, the assumption that the signal attenuation
must have a linear relationship in a logarithmic scale with the b-value is no
longer valid, resulting in tensor diffusivities that are “apparent” (i.e., model
approximations) rather than “true” measures of restricted self-diffusion.
assessments because the same neurodegenerative process, e.g.,
axonal loss, could impact diffusivities differentially across WM
tract environments with different axon size distributions, packing
arrangements or degrees of myelination. Suppose, for instance,
an enlargement of the extra-cellular space of 20% due to axonal
loss; its impact on RD would be different, for example, in a sce-
nario where axons are lost sparsely than if a small bundle of large
myelinated axons degenerate together. In the latter case, if molec-
ular displacements were small relative to the “new” boundaries,
FA would be underestimated as a result. It may be desirable to
detect such diffusion-time dependencies (Baron and Beaulieu,
2014); but they imply that whole brain analyses would be biased
toward such phenomena if they were proven to be present in some
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FIGURE 5 | The “diffusion regimes.” (A) White matter is a complex—but
relatively ordered— microstructure primarily composed of nerve fibers
(axons) and glial cells. Axons are bundled together; their main role is to
transport substances intra-cellularly through microtubules and conduct
electricity to enable inter-communication between cells. The myelin
sheath—a “fatty” insulating layer around the axons—facilitates such
conduction. In the healthy brain, such microstructure exerts restrictive
boundary conditions to water diffusion. (B) The exact mechanism by which
microstructural damage occurs in neurodegenerative diseases is unknown
but it is conceivable that, after a period of instability, demyelinative and
other axon degeneration processes will lead to longer “diffusion paths.” If
therefore, the diffusion time is sufficiently long and the gradients
sufficiently strong, such diffusion behavior will yield a change in signal
attenuation that will be reflected in tensor diffusivities. (C) If, however,
some diffusing molecules cease to interact with microstructural barriers
during a given diffusion time, the axial to radial relationship would be
dependent on the local geometry leading to heterogeneous tensor
behaviors across the brain. (D) In the extreme case, where the diffusion
time is too short for molecular displacements to be hindered, tensor
diffusivity measures would be unable to detect further change. Large
b-values—enabling long diffusion times and strong gradients—make the
diffusion measurement with magnetic resonance both more sensitive to
subtle microstructural alterations in highly restricted environments, and
less prone to diffusion-time dependencies.
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diseased regions but not in others. Furthermore, there might be
scenarios of extreme degeneration, or CSF contamination in a
voxel, where the majority of water molecules behave as in an
unrestricted medium; under such circumstances, further loss of
microstructural integrity would lie largely undetected with DTI
because water mobility would not reflect the presence of any
boundary (as in Figure 5D).
While these important theoretical considerations and lim-
itations should not be ignored, DTI can be very useful to
probe abnormal tissue microstructure. For instance, in a pseudo-
Gaussian scenario where several fiber tracts are damaged as a
consequence of a disease, diffusion hindrance would be reduced
(see Figure 5B), i.e., pdf s would approximate more readily to a
Gaussian distribution, and would return greater diffusivity values
closer to the intrinsic unrestricted self-diffusion coefficient; it is
this change in diffusivity pattern that can indicate abnormality in
degenerative disease states. In addition, because the tensor model
yields three rotationally invariant—and orthogonal—diffusivities
(λ1, λ2, and λ3), a disproportionate diffusivity change along a
particular orientation will impact on absolute (axial and radial)
diffusivities, or composite measures of diffusion anisotropy such
as FA as illustrated in Figure 3.
It is presently unknown whether diffusion-time dependencies
might be a confounding force in the study of neurodegenera-
tive diseases; for now, they remind us that caution must be at
the forefront in DTI interpretations. Unfortunately, DTI studies
in neurodegenerative diseases have often been guilty of over-
interpreting results, particularly when such interpretations are
based on consistency with prior knowledge rather than offering
a proof of a given mechanism. Mechanisms underpinning DTI
changes in clinical cohorts are often inferred by citing homol-
ogy with controlled animal experiments or computer simulations,
where processes such as myelin loss, fiber reorganization, changes
in membrane permeability, etc, are modeled in isolation—for a
extended review see Beaulieu (2002). Reductionist approaches
such as animal experiments are important in that they can high-
light the types of neural changes that are possible to detect with
DTI but there is a potentially serious error in logic when such
observations are exported directly to explain changes observed in
human neurodegeneration. For instance, if a given DTI change
has been observed in an animal model of demyelination and then
the same DTI change is observed in a degenerative disease, one
will often read that the mechanism in the latter is also demyeli-
nation. The error in logic is that there are only a finite number
of ways in which the diffusion tensor can change, and for any
given change, it is incorrect to assume that only one mechanism
might be the explanation—there may be many different types
of pathological change that could cause the same diffusion ten-
sor alteration. Using a clinical analogy, this is the same error
in logic as stating that because sub-arachnoid hemorrhage can
cause headache, any person with a headache must have a sub-
arachnoid hemorrhage. Furthermore, it seems highly unlikely
that a single mechanism will dominate the diffusion weighted
MR signal because fiber degradation processes such as Wallerian
degeneration—which typically involve the complex combination
of cytoskeleton dissolution, contraction, fragmentation, disin-
tegration of myelin and glial disposal (Coleman and Freeman,
2010)—are unlikely to occur simultaneously across all cells in a
single measurement voxel. Such complexity, worsened by the dif-
fusion regime uncertainty, suggests that DTI results should not
be interpreted beyond their canonical form—i.e., that increased
(or reduced) diffusivities are caused by less (or more) restric-
tive barriers to water diffusion, and that diffusion anisotropy
alterations are driven by orientation dependent changes in the
configuration of such microstructural arrangement. What these
exactly represent in neurobiological terms can only be speculated.
Nevertheless, DTI-derived diffusivity and anisotropy measure-
ments can offer important mechanistic insights toward under-
standing the sequence of events that lead to neurodegeneration by
highlighting tracts that are diverging from normality, even if dif-
fusionMRI, at present, cannot precisely state what the underlying
pathology driving such divergence might be.
TECHNICAL CONSIDERATIONS FOR CLINICAL DTI STUDIES
Historically, T1-weighting has been the MRI contrast of choice
to study structural abnormalities in the human brain. It is clear
that imaging parameter discrepancies or different field strengths
result in differential method sensitivity, but overall they tend to
be relatively concordant if the same processing steps are used.
This is because structural MRI post-processing methods typi-
cally concentrate on resolving and standardizing different types
of tissue using large amounts of prior anatomical knowledge; this
makes such analysis strategies relatively immune to differences,
e.g., in signal-to-noise ratio (SNR). Unlike structural MRI, how-
ever, DTI relies on quantitative information to yield meaningful
assessments; thus, DTI sensitivity and stability strongly depend
on how robustly the signals have been acquired. Therefore, addi-
tional precaution must be taken when reviewing the literature
because the ability of diffusionMRI to accurately reconstruct ten-
sorial information strongly depends onmeasurement SNR, which
varies throughout the brain, between subjects and across stud-
ies. It is likely that when non-specialists read an imaging study,
acquisition details—which may seem an impenetrable paragraph
of technical jargon—are skipped over. Such information though
is critical to DTI because some acquisition protocols that have
been applied in clinical studies are simply not fit for purpose.
It is beyond the scope of the present manuscript to discuss in
detail every relevant factor—for a more specialized review, see
e.g., Jones and Cercignani (2010)—but to help readers to criti-
cally evaluate the literature in this ever-growing field, a number of
the most clinically relevant technical considerations will be briefly
discussed:
THE DTI ACQUISITION SCHEME
The “b-value” is the parameter that tunes how much microstruc-
tural information the diffusion MR signal can carry. Relatively
large b-values are needed to ensure both (i) that strong dif-
fusion gradients sensitize water motion in complex, highly
restricted environments, and (ii) that the diffusion time is suf-
ficiently long to enable “meandering” diffusion paths to probe
less restricted (or diseased) microstructure. Early computer sim-
ulations suggested that for a single non-zero b-value experiment,
b = 1250 s/mm2 minimizes fitting errors for a mean diffusivity of
0.7 × 10−3 mm2/s, i.e., approximately that of brain parenchyma
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(Xing et al., 1997). More recent simulations have demonstrated
that even taking the simplification that the human brain is con-
stituted by single-orientation fiber populations, i.e., that crossing
fibers are not present, the b-value—if interested in MD and FA—
should not be lower than b = 900 s/mm2 (Alexander and Barker,
2005). Such results highlight a pitfall with a large number of
studies—particularly at 1.5 Tesla (T)—that used a maximum b-
value of 700 s/mm2. Capturing high order signal decays reflecting
non-Gaussian restricted diffusion with a smaller-than-optimal
single non-zero b-value translates to inaccurate “fits,” which, as
illustrated in Figure 4B, may lead to tensor reconstructions that
do not accurately reflect the true diffusion process, and hence,
the underlying microstructure. The use of larger b-values—closer
to optimal for tensor estimation in WM—can help reduce such
residual errors, but high b-values further attenuate the MR sig-
nal; thus, in order to ensure that diffusion-weighted signals are
well above the “noise floor,” a common practice is to take advan-
tage of the higher baseline SNR at stronger magnetic fields (e.g.,
3T MRI). It should be noted, however, that stronger fields are not
always favorable for DTI because the diffusion-weighted signal is
also T2 dependent, and T2 is shorter for stronger fields, which,
in turn, translates to faster signal decays. This is undesirable, and
poses a serious challenge, particularly at ultra-high field (7T and
above), because whole brain DTI acquisitions typically consist of
a single-shot echo planar imaging (EPI) pulse sequence with long-
lasting diffusion and readout gradients resulting in long delays
before the signal can be acquired, i.e., long echo time. At 3T, how-
ever, the gain in baseline SNR usually overcomes the T2 penalty;
that is why presently 3T MRI is the platform of choice for diffu-
sion tensor neuroimaging. It is noteworthy, looking to the future,
that low SNRs will become less of a problem for clinical studies
with the advent of high performance gradient systems capable
of stronger field gradients with shorter switching times, which
enable the use of higher b-values with shorter echo times.
Returning to the present, it is important to avoid low SNR
because the noise floor may damp signal decay, resulting in arte-
factually reduced diffusivities; this effect is orientation dependent
in the WM because faster signal decays—caused by greater diffu-
sivities along tracts—are more vulnerable to this effect, resulting
in artefactual reductions of diffusion anisotropy. This is critically
important because if one is attempting to map the distribution
of WM change in degenerative brain disease it is possible to
miss changes in affected areas where the local fiber orientations
were more vulnerable to the effects of low SNR. Signal levels
are modulated by the magnetic field strength, the type of radio-
frequency coil used and imaging parameters such as the echo
time (TE); number of b-values (Nb); number of repeat excitations
(NEX); receiver bandwidth or parallel imaging acceleration, e.g.,
GRAPPA (Griswold et al., 2002) or SENSE (Pruessmann et al.,
1999). Unfortunately, however, SNRs are not usually reported
in the literature. In addition, details about the number of chan-
nels available in phased-array coils, acceleration factor or receiver
bandwidth are also often not reported in clinical studies, mak-
ing comparisons between works hard to interpret from methods
sections.
The influence of suboptimal gradient sampling schemes is
also an important factor to consider when scrutinizing the
literature. Diffusion weighting along six unique orientations (see
Figures 2A,B) and the acquisition of a reference non-diffusion
weighted (or b0) image are the minimum requirements to recon-
struct DTI parametric maps; but to ensure primary diffusivities
are independent of fiber orientation—i.e., to ensure DTI metrics
are rotationally invariant –, one has to probe diffusion behav-
iors evenly and at a high spatial frequency. This is because
tensor eigenvalues, hence diffusivities and anisotropy estimates,
are more robust when WM tracts are collinear with one of the
motion-sensitizing gradients (Jones, 2004). It is, therefore, essen-
tial that large numbers of diffusion-encoding orientations (Nd)
are used for accurate DTI measurements in whole brain studies.
In fact, the minimum number for robust tensor reconstruc-
tion has been estimated to range between Nd = 20 (Papadakis
et al., 2000) andNd = 30 directions (Batchelor et al., 2003; Jones,
2004), though a recent computer simulation has shown that a
number of directions as low as Nd = 12 can yield accurate MD
estimates if the number of b-values is sufficiently large, e.g.,Nb =
5 (Correia et al., 2009). Interestingly, such robust behavior with
respect to noise could not be replicated using repeat measures
(NEX = 5) with a single b-value. This work, therefore, highlights
the importance of collecting more than one b-value—untrue for
NEX > 1—both to sensitize the DTI measurement to a wider
range of diffusivities—i.e., microstructural environments—and
to reduce the measurement bias due to noise. In clinical research
practice, however, the number of measurements, Nm, is typically
limited to 60–70 for a total scan time of 10min; hence an optimal
compromise between Nd and Nb must be achieved. Correia et al.’s
DTI simulation revealed that for Nm = 60 measurements, if the
interest is in MD, Nd = 12 × Nb = 5 is the optimal set-up—i.e.,
a large number of b-values is preferred. For FA estimation, how-
ever, a larger number of directions—Nd ≥ 30 (as in Batchelor
et al., 2003; Jones, 2004)—is needed to establish accurate axial-
to-radial diffusivity relationships, whereas little gain was observed
for Nb > 2. Therefore, an important outcome of these studies
is that Nd = 30 × Nb = 2 appears to be a good compromise to
ensure that tensor reconstructions are reliable; leading to the
notion that the majority of clinical studies—typically sensitized
with a single b-value and often, Nd ≤ 15 with NEX ≥ 2—may
have led to poor measurement stability.
An additional factor that may play a role in DTI robust-
ness is the accurate estimation of S0 through multiple b0 scans
(Nb0). To our knowledge, this has not been systematically inves-
tigated, though in theory its impact will depend on SNR (TE,
parallel acceleration factor, etc), and on the prescribed num-
ber of b-values—becoming less relevant with increasing Nb. It is
conceivable, however, that a large Nb0 can help stabilize the mea-
surements for little additional scan time—particularly in single
b-value experiments.
Figure 6 illustrates the choice of b-value, Nb and Nb0 depen-
dence on DTI reconstructions. All maps were inferred from
subsets (or the complete dataset) of a single acquisition with
Nd = 30, two non-zero b-values (b = 700 and 1000 s/mm2) and
Nb0 = 12—i.e., Nm = 72. Notable improvement in the cal-
culation of diffusivities and anisotropy can be observed with
the increase in b-value from 700 to 1000 s/mm2. As would be
expected, further improvements are noticeable when using the
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information from both b-values in combination; though the
highest diffusivity-to-noise ratios are returned by the complete
dataset with a larger number of b0 scans. It is, therefore, clear that
they all contribute to improving DTI measurement stability.
Correia et al. (2009) showed that measurements from subop-
timal schemes quickly deviate from true simulated values with
decreasing SNR; but SNR is not only dictated by the factors
enumerated above, but also by image resolution. One finds a
plethora of voxel sizes in the published DTI literature. In the
best case scenario, images are composed of isometric 2 × 2 ×
2mm3 voxels, but a large number of studies—particularly early
research at 1.5T—used slices more than twice as thick as in-plane
resolution to ensure sufficient measurement SNR. Non-isometric
voxels, however, are undesirable for volumetric analyses because
they encourage volume averaging along the slice direction, which
translates to spurious direction-dependent error biases (Oouchi
et al., 2007). An alternative would be to encode smaller matri-
ces with larger isotropic voxels, which is common practice, but
FIGURE 6 | Comparison of DTI parametric maps with different
b-value, number of b-values (Nb) and number of b0 scans (Nb0).
MRI measurements were performed on a Siemens Verio 3T system
(Siemens Medical Systems, Erlangen, Germany)—gradient coils capable
of 45mT/m and 200T/m/s slew rate—with a 32-channel phased-array
head-coil. Diffusion volumes were acquired using a standard
twice-refocused, single-shot EPI pulse sequence: repetition/echo time =
9000/94ms; matrix, 120 × 120; 63 contiguous slices aligned parallel to
the anterior commissure/posterior commissure line; voxel size: 2 × 2×
2mm3; 7/8-phase partial Fourier; bandwidth of 1667Hz/pixel and echo
spacing of 0.68ms. Diffusion gradients were applied along Nd = 30
non-collinear directions (Siemens default vectors) with Nb = 2 non-zero
b-values (b = 700 and 1000 s/mm2), and Nb0 = 12 reference scans.
Parallel imaging was enabled (GRAPPA, acceleration factor = 2 and 38
reference lines), leading to a total scan time of 11min and 15 s. DTI
maps were computed with standard tools from FSL’s diffusion toolbox.
(Left to right columns): (i) Nb = 1 (b = 700 s/mm2), Nb0 = 1 (5:06); (ii)
Nb = 1 (b = 1000 s/mm2), Nb0 = 1 (5:06); (iii) Nb = 2 (b = 700 and
1000 s/mm2), Nb0 = 1 (9:36); (iv) Nb = 2 (b = 700 and 1000 s/mm2),
Nb0 = 12 (11:15).
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one should not ignore that partial volume effects caused by large
measurement voxels can also be highly detrimental in DTI due
to GM and/or CSF contamination. This, in turn, can lead to sys-
tematic errors in patient populations because typically patients
have more brain atrophy than controls, and therefore, DTI alter-
ationsmay reflect CSF inclusions rather than truemicrostructural
changes. It should be noted that the WM tract of interest in the
present Research Topic—the fornix—due to its close vicinity to
ventricular CSF is particularly vulnerable to this phenomenon as
illustrated in Figure 7.
In conclusion, although DTI is becoming a mature technique,
there is not yet a universal agreement on the minimum require-
ments for a reliable DTI acquisition, or on an optimal image
acquisition scheme for a given scan time, so we must reconcile
with the fact that different DTI studies to date may have sensitized
their acquisitions very differently.
THE POST-PROCESSING METHODOLOGY
Post-processing methods are also highly relevant to interpreting
DTI literature. To date, a number of analysis strategies have been
used including region-average, histogram or voxel-/cluster-based.
No method, however, has demonstrated systematic superiority
in every scenario; though it is widely accepted that for unbi-
ased whole-brain assessments, the tract-based spatial statistics
(TBSS) approach (Smith et al., 2006) has advantages and is the
most desirable technique for volumetric DTI analysis at present
(see Figure 8). TBSS—part of FMRIB’s software library or FSL
(Smith et al., 2004)—enables whole brain assessment ofWM tract
integrity in neurodegenerative diseases using DTI data without
the need for a priori hypotheses about the spatial location of
degenerative involvement. TBSS circumvents the lack of anatom-
ical landmarks in WM, which is a limiting factor for manual
tracing of tracts of interest in native space. TBSS deals with this
problem by automatically co-registering all DTI parametric maps
to a standard template; also, unlike histogram analyses, it can
resolve the specific location of abnormal clusters; it is not biased
by the dependency issues known to affect tractography based
regional analysis (Besseling et al., 2012); and finally, TBSS does
not require convolution with a smoothing kernel, as is used in
standard VBA methods, due to the introduction of a skeleton-
isation step. The skeleton is derived from averaging FA images
across all subjects and subsequent identification of tract centers;
FIGURE 7 | White matter tracts that are usually prone to measurement
error. (A) The body of the corpus callosum (top arrow) and the body of the
fornix (bottom arrow) are often problematic because they are adjacent to
cerebrospinal fluid. The cingulum bundle, (B) which is typically less
vulnerable at the level of the posterior cingulate, (C) is sometimes prone to
partial volume contamination and other types of measurement error in the
parahippocampal region due to its thinner physical appearance (Jones et al.,
2013a) and its closer proximity to rostral temporal areas known to be affected
by magnetic susceptibility artifacts. Note in addition that orbitofrontal white
matter is also vulnerable to such artifacts.
FIGURE 8 | Tract-based spatial statistics (TBSS) processing pipeline. (Left
to right) DTI-derived fractional anisotropy (FA) images are co-registered to a
template; they are then averaged, from which a “skeleton” containing all
major tract centers common to all subjects is derived. Skeleton voxels with
low FA-values (typically FA < 0.2) are excluded to ensure only white matter is
present. Next, spatially normalized FA images are projected to the skeleton.
In this step, the center of each tract is identified for each individual FA image,
and projection vectors to their analogous location in the skeleton are
computed and applied. Transformation fields (to template space) and
projection vectors (to the skeleton) are then also applied to the additional DTI
parametric maps (i.e., MD, λ1, RD). Finally, non-parametric, permutation
based, statistical testing of the null-hypothesis is performed.
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this ensures the analysis is carried out exclusively on definite
WM. But the main advantage of projecting DTI data to a WM
skeleton is that it corrects, to some extent, co-registration inac-
curacies, rendering the data more comparable than in VBA. In
addition, performing statistics only along the center of major
WM bundles minimizes the effects of partial volume contami-
nation and reduces the number of statistical tests. Furthermore,
TBSS’ non-parametric statistical method does not require nor-
mally distributed data and, as for any randomization approach, it
is inherently robust against Type-I errors (Winkler et al., 2014).
The default TBSS processing pipeline, however, suffers from
its own sources of inaccuracy and limitations: it fails to rotate
the B-matrix after realigning all images to account for motion
and eddy-current effects (Leemans and Jones, 2009); it imple-
ments a fast—but oversimplified—tensor fitting routine (Jones
and Cercignani, 2010) that assumes single fiber populations in
each voxel, hence leading to potential miscalculations in areas of
crossing and kissing fibers (Jbabdi et al., 2010); its non-linear co-
registration algorithm, FNIRT, performs moderately relative to
other state-of-the-artmethods (Klein et al., 2009); assessments are
spatially restricted toWM tract centers only—ignoring, therefore,
a large amount of WM1; and finally, it suffers from spatial- and
orientation-dependent statistical sensitivity (Edden and Jones,
2011). That is, TBSS is not completely unbiased. Such limitations
should not be ignored; in fact, they suggest that in certain scenar-
ios other methods might be preferable. For example, the fornix
is often excluded from the WM skeleton due to the perennial
issue of image misregistration (Keihaninejad et al., 2012) or does
not survive correction for multiple comparisons at the cluster
level due to its small physical size (Acosta-Cabronero et al., 2012;
Schwarz et al., 2014). The fornix, however, has clear boundaries
in FA maps (at least through the midline), and more advanced
co-registration methods exist; thus, although FNIRT-based TBSS
studies in AD will be the focus here to homogenize the potential
confounding error introduced by different post-processing rou-
tines and because, to date, it is the most widely used method of
whole-brain DTI analysis, it should be highlighted that manual
tracing or automated regional extraction using high-performing,
tensor-orientation enabled (Zhang et al., 2006) or intensity-
based, diffeomorphic image registration algorithms (Avants et al.,
2008)might be better suited to study structures such as the fornix.
Turning to the issue of image misregistration with standard
FSL tools, a recent study has compared the warping performance
for a number of co-registration strategies, including the stan-
dard TBSS procedure of warping each subject to the FMRIB’s
FA template (ST-TBSS), the previously recommended method
of using the most representative subject as an intermediate reg-
istration step (RS-TBSS), and building study-specific (SS-TBSS)
or group-wise templates (GW-TBSS)—all in the context of AD
1In practical terms, however, this is not a problem for neurodegenerative dis-
eases in which degeneration involves large-scale networks as opposed to tiny
focal lesions. Visual inspection of a skeleton typically demonstrates that TBSS
does not systematically miss any large chunks of the brain. In fact it can be
desirable, particularly in neurodegenerative diseases, where the data reduction
step to tract centers eliminates to a greater extent the vulnerability to partial
volume contamination due to focal lesions.
(Keihaninejad et al., 2012). The lack of ground truth makes
the visual assessment of TBSS results in AD hard to interpret;
however, using inter-subject variability and a proxy-measure of
false positive rate as indicators of overall warping performance,
Keihaninejad et al.’s results suggest that RS-TBSS is substantially
inferior to the other methods, and that the use of the GW-TBSS
approach might be beneficial.
THE SUBJECT COHORT
An important factor that must be considered is the nature of
the patient cohort under investigation. Many studies focus on
the prodromal stages of AD—typically patients diagnosed with
subjective or mild cognitive impairment (SCI/MCI), genetically
at risk (e.g., carriers of the apolipoprotein E ε4 allele), and/or
those who are positive for an AD biomarker, e.g., CSF analysis
or amyloid-ligand PET. It is noteworthy, however, that not all
risk indicators are equivalent; while amyloid-PET is an unam-
biguous marker of AD neuropathology (Clark et al., 2012), CSF
markers are not as robust due to inconsistent standardization
(Verwey et al., 2009). In addition, genetic risk profiles (for spo-
radic AD) are problematic because they are only risk factors.
Most troublesome, though, are studies that report cross-sectional
cohorts of SCI or MCI with neither biomarker nor longitudi-
nal outcome data to confirm symptoms were due to early AD.
Cohorts without such information are impossible to interpret
because of the potentially large number of false positive cases
meeting such inclusion criteria (Jicha et al., 2006). This prob-
lem can be further compounded if imaging studies stratify MCI
into amnestic (aMCI), non-amnestic (naMCI) andmulti-domain
(mdMCI), or, into “early” and “late” MCI without outcome or
biomarker data. Individuals belonging to an mdMCI or late MCI
group, being more cognitively impaired, have a higher probabil-
ity of having AD, while naMCI has a lower probability (Mitchell
et al., 2009). These are, however, only probabilities and do not
indicate the pathology of each individual in a group. If the aim
is to study the neurobiology—as it should be in an imaging
study—of prodromal AD, a subject with naMCI due to AD is
an appropriate inclusion whereas one with mdMCI that is not
due to AD pathology is not. The present review, therefore, will
not discuss such studies unless outcome data through clinical
follow-up, or amyloid-PET/CSF analysis, confirmed that subjects
in these pre-dementia stages were likely to have had incipient AD.
It should be noted that meeting established criteria for proba-
ble AD (McKhann et al., 1984) does not completely predict AD
neuropathology at autopsy, but the risk of including false positive
cases is far lower than for SCI/MCI.
A further confounding effect that must always be considered
is the comorbidity of WM hyperintensities. Studies typically deal
with this by excluding cases with such lesions through visual
inspection of T2-weighted images; this can also be supported by
semi-quantitative measures using the Fazekas visual rating scale
(Fazekas et al., 1987). It should be highlighted, however, that
there is no consensus on what constitutes an unacceptable level of
lesion burden for a DTI analysis in dementia although such infor-
mation is very relevant given the extremely high prevalence of
WM hyperintensities in the target population. This would be an
interesting topic for further research, as would more automated
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and quantifiable measures of lesion load. For instance, it seems
reasonable that subjects with negligible amounts of WM signal
change would still be appropriate for inclusion in a DTI study,
but this immediately raises the question of how one defines “neg-
ligible.” More objective scales and a consensus on an acceptable
threshold would, therefore, be desirable.
MULTI-CENTER STUDY DESIGNS
Multi-site designs are becoming increasingly common in AD
research, particularly with the advent of the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) and related spin-offs (Jack et al.,
2010). Whilst such initiatives incorporate a pilot stage to estimate
measurement stability across centers, a systematic assessment of
inter-site DTI variability has not yet been carried out within the
ADNI framework. An independent European initiative, however,
performed such measurements and found significant FA varia-
tions across scanners, leading to the conclusion that FA variability
cannot be fully controlled by the use of identical scanner type and
acquisition parameters (Teipel et al., 2011). This result highlights
that, at least until full cross-validations confirm otherwise, multi-
center studies should account for potentially confounding scan-
ner effects—a practice that is not commonly carried out. It should
be noted, therefore, that multi-center studies in the present review
have been included only to confirm widely reproduced observa-
tions, but little emphasis has been given to idiosyncratic results
generated from such datasets.
LITERATURE SYNTHESIS: INCLUSION CRITERIA
In an effort to evaluate the DTI literature to date in AD, stud-
ies meeting the “essential” criteria for this review (Table 1) were
selected. Table 2 illustrates the iterative process that led to iden-
tification of 13 publications in which an acceptable acquisition
and analysis protocol was employed; and in which patients had
either clinically probable AD, MCI-stage AD where longitudi-
nal follow-up or biomarkers were used to define probable AD
status, or patients with autosomally inherited known gene muta-
tions for AD (Acosta-Cabronero et al., 2010, 2012; Douaud
et al., 2011; Bosch et al., 2012; Huang et al., 2012; Canu et al.,
2013; Fieremans et al., 2013; Mahoney et al., 2013; Nir et al.,
2013; Rowley et al., 2013; Ryan et al., 2013; Lim et al., 2014;
Molinuevo et al., 2014). It should be stressed that Table 2 high-
lights the order of iterations by which studies were excluded;
it should not be read to mean that for each criterion the
number of excluded studies equals that number of studies in
total that failed on that specific criterion because many stud-
ies failed on multiple criteria. Table 1 also includes a list of
proposals of additional criteria for future studies based on current
knowledge.
Details of the 13 studies that were identified from the literature
review can be found in the Supplementary Table. It should also
be noted that several of the studies (Douaud et al., 2011; Bosch
et al., 2012; Huang et al., 2012; Nir et al., 2013; Rowley et al.,
2013) included both AD andMCI groups where the latter did not
Table 1 | Selection criteria for DTI studies in Alzheimer’s disease included in the present review and additional guidelines for future studies.
Essential (inclusion criteria for this review)
DTI ACQUISITION
 Number of diffusion-encoding directions equal to or greater than 30
 Quasi-isometric voxels—ratio between in-plane resolution and slice thickness greater than 0.75, i.e., the geometry of 1.875 × 1.875 × 2.5mm3 voxels
is at the lower limit
 Voxels smaller than 20mm3, i.e., image resolution 2.7 × 2.7 × 2.7mm3 is at the upper limit
Maximum b-value equal to or greater than 900 s/mm2
STUDY COHORT
 (i) Clinical diagnosis of probable AD (at acquisition or through clinical follow-up), (ii) positive CSF analysis for AD (iii) positive amyloid-PET, or (iv)
autosomal dominantly inherited mutation carriers
 Number of subjects equal or greater than N = 10 in each group
DATA ANALYSIS
 Voxel-/cluster-wise (or region-average) whole-brain TBSS
 Show results for both FA and MD (at least)
 Demonstrate results are robust against multiple testing effects
Desirable (additional suggested criteria for future studies)
DTI ACQUISITION
+ Studies performed on a single scanner
+ Use of multiple b-values, i.e., Nb ≥ 2
+ If Nb = 1, total number of measurements greater than 60, i.e., Nm > 60
+ Ensure stable S0 measurement, i.e., Nb0 ≥ 5
+ Voxels equal to or smaller than 8mm3, i.e., image resolution 2× 2× 2mm3 or finer
+ Perfect voxel symmetry (or within 90%)
DATA ANALYSIS
+ Avoidance of RS-TBSS pipelines
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Table 2 | Summary of the hierarchical iterative steps leading to the selection of 13 DTI studies in Alzheimer’s disease.
# of studies Remaining
1. PubMed search (“diffusion tensor” OR DTI) AND (Alzheimer’s) on 5/8/2014 476
2. Not relevant (i.e., tractography based structural/functional connectivity studies, DTI works
with marginal reference to AD, etc)
285 191
3. Not TBSS (i.e., VBA, ROI, atlas-based, etc) 118 73
4. TBSS in MCI or ApoE4 carriers without clinical outcome or additional biomarker 27 46
5. TBSS in AD using images with unacceptably thick scan slices 11 35
6. TBSS in AD using an insufficient number of diffusion-encoding directions (i.e., Nd < 30) 10 25
7. TBSS in AD using low maximum b-value (i.e., bmax < 900 s/mm2) 4 21
8. TBSS in non-representative groups (i.e., N < 10 AD subjects) 2 19
9. TBSS to study AD-related aspects not directly relevant to this comparison (e.g.,
investigation of neural correlates)
2 17
10. TBSS in AD with a non-conventional statistical approach 1 16
11. TBSS in AD where no contrast against controls was shown 1 15
12. TBSS in AD where only the FA contrast was shown 2 13
Selected TBSS studies in AD 13
meet entry criteria for the present review. Only data from the AD
groups is included from such studies.
TBSS IN AD: FINDINGS FROM THE LITERATURE OVERVIEW
After careful literature filtering for potential technical problems
in past studies, a number of consistent TBSS behaviors were
identified; it would be wrong to assume, however, that such
results provide a definitive understanding of WM changes in AD
because, as discussed, alterations in structures that are prone
to error may lie undetected for technical reasons. In contrast,
prominent DTI effects that have been reproduced in a number
of methodologically sound studies are evidence of real phenom-
ena and that may, thus, be interpreted with scientific rigor as
disease-related processes.
WHAT DOES THE DISTRIBUTION OF DIFFUSION TENSOR ALTERATIONS
TELL ABOUT AD?
The selection process identified TBSS studies in AD that gen-
erally had a consistent common denominator—i.e., widespread
and confluent tensor abnormalities in parietal, temporal and
pre-frontal WM—specifically involving long association fibers
(including limbic tracts) and inter-hemispheric connections
through the corpus callosum. Generally speaking changes were
more apparent in posterior areas compared to frontal areas as
would be expected from prior knowledge of cortical atrophy stud-
ies and FDG-PET. Figure 9 exemplifies such a distribution in
a mild AD cohort (Acosta-Cabronero et al., 2012), where the
posterior corpus callosum, cingulum bundle at the level of the
posterior cingulate gyrus, superior longitudinal fasciculus and
sagittal stratum (including the inferior longitudinal fasciculus,
fronto-occipital fasciculus, and posterior thalamic radiation)
were affected. Additional involvement is also commonly found
in superior temporo-parietal WM at the level of the corona radi-
ata and centrum semiovale—composed of intertwined long/short
association and projection tracts.
Two exceptions, however, were found; the studies by Ryan et al.
(2013) and Lim et al. (2014) did not find any cross-sectional
differences in pre-symptomatic, autosomal dominant (PSEN1)
mutation carriers and a group of MCI-stage AD patients defined
by CSF biomarkers, respectively. The group reported by Ryan
et al. (2013) were estimated to be a mean of 5.6 years from symp-
tom onset so it simply may be that the group was too early to
have major changes in WM; to this end it was notable that as
a group there was also no significant hippocampal atrophy. The
group only comprised N = 10 mutation carriers which also sug-
gests it may have been underpowered to detect subtle changes
with whole brain TBSS analysis; finally, the control group used
was significantly older than the PSEN1 group which may have
also masked abnormalities. The cohort in Lim et al. (2014) were
N = 16 early MCI-stage AD subjects scanned under the umbrella
of the ADNI2 framework, i.e., on 14 different scanners, which
may, thus, have contributed to the lack of sensitivity. Though one
might be tempted, in light of these results, to conclude that DTI
is unable to detect WM changes in such early stages, the post-hoc
regional study carried out by Ryan et al. (2013); the TBSS study
by Molinuevo et al. (2014) in a group of cognitively normal and
SCI subjects (positive for CSF biomarkers); and an atlas-based
regional study (with suitable methods) in cognitively normal
(amyloid-PET positive) subjects (Racine et al., 2014) suggest oth-
erwise, as these reported DTI alterations that were consistent with
the distribution in Figure 9.
The results from Canu et al. (2013) are also worthy of further
discussion. The study examined two AD cohorts with differ-
ent onset ages, but matched otherwise for disease severity, with
two appropriately age-matched control groups. The early-onset
group showed very widespread abnormalities highly concordant
with Figure 9, but that spread slightly more anteriorly along
association tracts and the genu of the corpus callosum. These were
moderately impaired cohorts, i.e., average mini-mental cognitive
examination (MMSE) score (Folstein et al., 1975) around 20/30;
thus it would be reasonable to expect that changes had extended
more extensively into frontal areas. Interestingly, however, the
result in the late-onset cohort was relatively insensitive. Whilst
differences were found in posterior areas largely overlapping the
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FIGURE 9 | TBSS in AD. TBSS results for N = 43 early-stage AD patients
(age: 70 ± 6, <MMSE>= 24± 4) vs. N = 26 matched controls (age:
68 ± 6) (Acosta-Cabronero et al., 2012). Pink clusters denote increased
MD in patients, whereas those in yellow represent FA reductions at
P < 0.05 enabling threshold free cluster enhancement (TFCE) (Smith and
Nichols, 2009) and controlling the family-wise error (FWE) rate.
Thresholded statistical maps are overlaid onto the TBSS skeleton and
MNI152 template. Sagittal MNI coordinates are given in millimeter where
x < 0 is left. Abbreviations: [SLF] superior longitudinal fasciculus; [SS]
sagittal stratum; [CR] corona radiata; [s/b/gCC] splenium/body/genu of the
corpus callosum; [CGc/h] cingulum at the level of the posterior
cingulate/parahippocampus; and [FX] fornix.
clusters in Figure 9, the distribution was markedly less exten-
sive, which was interpreted as less severe damage than in the
earlier-onset group of patients.While this might be true, the study
highlights another potentially important confound; that is, the
age of the control group. Themean age of controls for the contrast
with “late-onset” ADwas 73 years but at this age one would expect
around one third of a control population to be amyloid posi-
tive, i.e., in the pre-clinical stage of AD (Villemagne et al., 2011).
In contrast, the control group for the early-onset AD cohort
had a mean age of 59 years—an age at which one would expect
negligible, if any, contamination from pre-clinical AD. In other
words, older control subjects are probabilistically more likely to
introduce undesirable variability into group comparisons, which
may explain some of the differences in sensitivity across stud-
ies. This suggests that when targeting “late-onset” AD, it would
be desirable in future that the control group was defined by
being amyloid-negative, in addition to being cognitively intact, to
ensure that this possible confound was not attenuating sensitivity.
Studies in symptomatic, young PSEN1 carriers (Ryan et al.,
2013), or in relatively young sporadic AD cohorts (age: 63 ± 5,
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Mahoney et al.), where control groups were young and abnor-
malities, very extensive—with posterior predilection but spread-
ing toward anterior areas—also support the notion that control
age might be a contributing factor affecting analysis sensitiv-
ity. However, extensive abnormalities are not a unique feature
of young cohorts, a number of studies in older groups have also
shown a similar behavior, e.g., mild AD in Fieremans et al. (2013),
mild AD in Acosta-Cabronero et al. (2012), mild AD in Douaud
et al. (2011), mild AD (ADNI data) in Rowley et al. (2013) and
mild AD (ADNI data) in Nir et al. (2013). In such studies, the
posterior parietal and superior temporal regions highlighted in
Figure 9 were key features, but abnormalities also spread more
anteriorly along association tracts and also included extensively
the anterior corpus callosum, corticocortical association fibers
running through the external capsule and the anterior limb of the
internal capsule. Disentangling whether more, or less, widespread
distributions across studies are the result of subtle technical fac-
tors, differences in disease severity, in control variability, or in
cohort size, is impossible to disambiguate, but it should be high-
lighted that from the selected studies, cohorts with the most
widespread abnormality patterns had, in general, more advanced
disease stages than the cohort displayed in Figure 9, suggesting
disease severity is a dominant factor in result sensitivity. A recent
study in two age-matched AD cohorts with different disease sever-
ity that controlled for all the above factors using the same acquisi-
tion, the same control cohort and the same number of subjects in
each patient group, showed evidence indicating a posterior first,
then more anterior distribution in more advanced disease stages
(Acosta-Cabronero et al., 2012)—matching the expected progres-
sion of degeneration as would be measured by cerebral glucose
metabolism (Minoshima et al., 1997; Nestor et al., 2003b). In
summary, although a number of additional factors might have
contributed to variability in result sensitivity across studies, dis-
ease staging appears to drive the overall distribution of WM
abnormalities in AD.
Focusing on the earliest DTI changes in AD specifically,
Molinuevo et al. (2014) studied a combined cohort of cogni-
tively normal subjects and SCI with a CSF profile consistent with
AD, while Acosta-Cabronero et al. (2012) reported on patients
with MCI-stage AD confirmed through longitudinal follow-up.
The two studies showed a consistent picture of the affected neu-
ral network in incipient stages of AD. Both results highlighted
involvement of parietal and superior temporal WM bilaterally—
spatial distributions that are also in close agreement with the
expected landscape of WM involvement that can be inferred from
the pattern of glucose hypometabolism in very mild AD (Nestor
et al., 2003b, 2006).
DIFFERENTIAL DIFFUSION METRIC SENSITIVITY DURING THE COURSE
OF AD
An interesting by-product of TBSS analyses in AD has been in
showing that alterations in diffusion behavior are complex—
while early (and some recent) studies tended to focus only
on FA—often leading to largely insensitive results (Damoiseaux
et al., 2009; Zarei et al., 2009; Balachandar et al., 2014)—, more
extensive abnormality distributions for MD have been a consis-
tent finding across studies (Acosta-Cabronero et al., 2010, 2012;
Douaud et al., 2011; Huang et al., 2012; Fieremans et al., 2013;
Mahoney et al., 2013; Nir et al., 2013; Rowley et al., 2013; Ryan
et al., 2013). What this behavior represents in neurobiological
terms, however, is unknown because, as discussed already, DTI
offers limited information about the geometry of the underly-
ing damaged microstructure. In contrast, what DTI enables us to
infer from such behavior is that WM degeneration in AD results
in alterations to WM tissue that are not grossly driven along any
preferential direction (Acosta-Cabronero et al., 2010). Subtle ori-
entation dependent behaviors missed by FA can be explored by
dissecting the apparent diffusion coefficient encapsulated in MD
into its primary components, i.e., λ1 (also commonly referred
to in the literature as AxD or DA) and RD. A superficial read-
ing of studies examining these primary components appear not
to provide a clear picture—a number of studies such as those
in very mild AD by Acosta-Cabronero et al. (2012) and in CSF-
positive SCI by Molinuevo et al. (2014) indicate that λ1 might be
the dominant source of DTI abnormalities; whereas other stud-
ies such as those in mild AD by Mahoney et al. (2013) and Bosch
et al. (2012), and inmoderately impaired AD by Ryan et al. (2013)
show greater RD effects. Douaud et al. (2011) proposed that the
λ1 increase could be explained as an artifact of loss of one fiber
population in areas of crossing fibers (see Figure 3). This would
be a plausible theory if increased λ1 were restricted to areas of
crossing fibers (e.g., centrum semiovale), however increased λ1
in AD is not limited to such regions: the same phenomenon is
observed in the midline corpus callosum and fornix where cross-
ing tracts are not present. This indicates that increased λ1 in AD
must be due to another mechanism but what that might be in
biological terms is, at present, unclear2.
The patient cohorts in Mahoney et al. (2013); Bosch et al.
(2012) and the symptomatic cohort in Ryan et al. (2013),
which all reported increased RD, had more advanced dementia
(MMSE < 23) than those outlined with extensive λ1 changes,
suggesting that on closer inspection of the literature, individ-
ual component metrics of the diffusion tensor may evolve along
different trajectories with disease progression. This implies that
different metrics may be more or less sensitive to different dis-
ease stages. This hypothesis was tested on two—very mildly
(MCI-stage) and mildly impaired—AD groups using the same
MR acquisition and post-processing methods (Acosta-Cabronero
et al., 2012). The distribution of increased λ1 involving poste-
rior temporo-parietal WM—largely consistent with Molinuevo
et al. (2014)—was identified as the first sign of change. In the
more advanced group, however, increased RD—which, in turn,
drove FA reductions—emerged in these regions that had shown
increased λ1 in the very mild group. As degeneration spread to
new areas—notably frontal and left temporal WM—increased λ1
2One possible situation where loss of crossing fibers may explain increased
λ1 was a study that examined the neural substrate of topographical memory
impairment in AD (Pengas et al., 2012). The study in question found corre-
lations between increasing λ1 and decreasing task performance; interestingly
the regions that correlated were all in close proximity to the cortical ribbon—
in other words, in the U-fiber layer. It is tempting, therefore, to speculate that
local degeneration of GM, in turn meaning less axons entering adjacent WM,
might lead to a simplification of the adjacent U-fiber layer—i.e., less crossing
fibers—making increased λ1 correlate significantly.
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was again the first abnormality to appear. These results suggested
that while λ1 increase is the first sign of change in a given loca-
tion, RD is relatively insensitive at the earliest disease stages but
becomes progressively more abnormal as the disease progresses.
Confirming this theory, a subset of AD patients in the same
study, who were scanned serially, revealed that RD/FA changes
emerged at follow up in areas where increased λ1 had been seen at
baseline. Interestingly, λ1 increases did not progressively worsen
over time with longitudinal follow-up. There was, furthermore,
no evidence for progressive worsening of λ1 between the two
severity stages in the cross-sectional cohorts when investigating
the midline splenium in isolation. In fact, if anything there was
a slight tendency for the increase in λ1 to lessen with advancing
disease (Acosta-Cabronero et al., 2012); in other words suggest-
ing that when a WM region first becomes affected in AD, there is
a sharp increase in λ1, that may possibly attenuate with further
disease progression.
In summary, RD progressively increases (and therefore FA
progressively decreases) as a function of disease severity—as
defined by degree of cognitive impairment—whereas λ1 does not
FIGURE 10 | TBSS in very mild AD. TBSS results for N = 21 very mild
AD patients (age: 72 ± 5, <MMSE>= 26 ± 2) vs. N = 26 matched
controls (age: 68 ± 6) (Acosta-Cabronero et al., 2012). The patient group
included N = 16 subjects who were scanned with a diagnosis of mild
cognitive impairment but were subsequently shown to have probable AD
with longitudinal follow-up. Black clusters denote increased λ1 in patients
at PFWE < 0.05, whereas those in blue represent changes with post-hoc
control over the false discovery rate (FDR) at q < 0.05. Thresholded
statistical maps are overlaid onto the TBSS skeleton and MNI152 template.
Sagittal coordinates are given in millimeter (x < 0 is left). Abbreviations:
[aTh] anterior thalamic white matter; [CGh] cingulum at the level of the
hippocampus; and [FX] fornix.
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progressively increase. That increasing λ1 is not a function of dis-
ease severity, at least in the midline splenium, suggests that the
early λ1 increase in AD may be capturing an upstream event to
axonal degeneration, whereas processes more directly related to
neuronal loss might dominate RD/FA dynamics—implying thus
that, whilst λ1 in the splenium could act as a state-specific marker
in prodromal disease stages, the spatial distribution of RD/FA
changes may be a more suitable staging biomarker.
FORNIX CHANGES IN AD
Although atlas-based approaches consistently find strong effects
in the fornix (Keihaninejad et al., 2013; Racine et al., 2014), this
was not, however, a universal feature of the TBSS studies reviewed
above. Such tracts are often excessively penalized due to their
small size by the strictness of non-parametric statistics control-
ling for family-wise error (FWE) rate. Using, however, the more
lenient false-discovery rate (FDR) correction (Benjamini and
Hochberg, 1995) to show abnormalities that are less prominent at
the cluster level—yet statistically robust—fornix changes emerge
also with TBSS analysis. Figure 10 illustrates the impact of this
slight statistical modification, resulting in “new” λ1 abnormalities
in the fornix, parahippocampal WM and anterior thalamus (pos-
sibly capturing change in the mammillo-thalamic tract). These
structures are not just random new blobs—they precisely target
major WM connections in the limbic-diencephalic network that
has been highlighted as the early hypometabolic landscape of AD
(Nestor et al., 2003b, 2006). For a focused review on the specific
role of the fornix in this network, including the possibility of it
being therapeutic target for deep brain stimulation in AD, see the
review in this Research Topic (Oishi and Lyketsos, 2014).
The notion that limbic tracts and the corpus callosum—
particularly the splenium—are key features in early stages of AD
has now a solid body of evidence. The theory that these regions
should show the most advanced degeneration in the course of
AD (and therefore be the first to show RD/FA changes) when
other areas, being less advanced in the course of disease, would
only show λ1 changes is strongly supported by the regional TBSS
analysis in mild AD carried out by Huang et al. (2012). These
authors found λ1 increase in association and projection tracts
and RD/FA effects in the corpus callosum, cingulum and fornix,
precisely suggesting that the latter were at a more advanced stage
of degeneration compared to the former. In a similarly impaired
cohort extracted from the ADNI dataset, Nir et al.’s regional
TBSS study also found strong RD/FA alterations for such struc-
tures. In addition, a prospective study—targeting specifically the
corpus callosum, fornix and cingulum—found significant cross-
sectional and longitudinal tensor differences for all three struc-
tures (Keihaninejad et al., 2013). The common aspect in these
studies is that—consistent with all the selected works—absolute
diffusivities were increased in AD relative to controls, whereas FA
was reduced.
CONCLUSION
In summary, the existing literature supports the theory that a
bilateral neural network that involves preferentially the cingulum
bundle, fornix and corpus callosum is vulnerable to early disease
processes triggered by the Alzheimer’s disease neuropathological
cascade. This suggests that the nodes that this network inter-
connects—i.e., the mesial temporal lobe, mammillary bodies,
thalamus, and posterior cingulate—degenerate as a network,
rather than in isolation.
To conclude with a note of caution and a window to future
research directions. While much effort was made to rationalize
published DTI studies in AD for this review, it remains possi-
ble that a large number of technical factors including suboptimal
acquisitions, poor tensor reconstruction routines, poor image co-
registration performance, or intrinsic DTI limitations, to name
a few, might still have resulted in some systematically incorrect
results across the literature, in turn, leading to incompletely valid
interpretations in this review. A number of technical develop-
ments, however, should hopefully soon help confirm, or reject,
the above theories: stronger gradient systems enabling larger b-
values, shorter echo times and smaller voxels; improved image
quality through multiband acquisitions (Frost et al., 2014); the
prescription of multiple b-values; the implementation into stan-
dard tensor reconstruction pipelines of distortion correction,
B-matrix rotation and multi-component fitting routines with a
free-water component (Pasternak et al., 2009); the application
of advanced diffusion models beyond the single tensor such as
diffusion kurtosis imaging (Jensen et al., 2005), NODDI (Zhang
et al., 2012), CHARMED (Assaf and Basser, 2005), or q-space
approaches such as q-ball reconstruction (Tuch, 2004) or diffu-
sion spectrum imaging (Wedeen et al., 2005); the use of state-of-
the-art co-registration methods (Zhang et al., 2006; Avants et al.,
2008); and a long et cetera.
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